Capital Flow Monitor · Sponsors · CIK 1690279
Nacuity Pharmaceuticals, Inc.
FORT WORTH CLUB BLDG., FORT WORTH, TX, 76102 · 817-336-3000
Pharmaceuticals · Corporation· inc. DELAWARE true
Fit score
—
Offering
$30.0M
Sold
$8.4M
% sold
28.0%
Investors
98
Min investment
$9K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-12-30 | D ·current | 506(b) | $30.0M | $8.4M | 28.0% | 98 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Halden Conner — Executive Officer / Director, Fort Worth, TX
- David Wohlberg — Executive Officer / Director, Fort Worth, TX
- Gerald Cagle — Director, Fort Worth, TX
- Emmett Cunningham, Jr. — Director, Fort Worth, TX
- Rusty Kelley — Director, Fort Worth, TX
- Robin Steele — Director, Fort Worth, TX
- Benjamin Yerxa — Director, Fort Worth, TX
- Jami Kern — Executive Officer, Fort Worth, TX
- Charles Lieser — Executive Officer, Fort Worth, TX
- Michael Wall — Executive Officer, Fort Worth, TX
Placement agents
- Maxim Group Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.